THE PROBLEM

Three blind spots in how joint disease is seen today.

Joint inflammation operates on three time scales. None of them are currently visible to standard care. We spoke to 50 patients, rheumatologists, and field experts. This is what they showed us.

ACT 01 · DIAGNOSIS

Years lost in plain sight.

Three patient journeys from our customer discovery interviews.

3 in 4 patients reported a difficult or delayed path to diagnosis.

LumiJoint customer discovery · 50 interviews

ACT 02 · EXAMINATION

The same day. Different exams.

What a rheumatologist sees depends on when they look.

A representative day from customer discovery

A REPRESENTATIVE DAY · PATIENT AND RHEUMATOLOGIST

09:30 AT HOME
the patient
14:00 IN CLINIC
the rheumatologist

same patient. same day. a few hours apart.

— composite, from LumiJoint customer discovery

What a doctor sees depends on the time of day

APPOINTMENT TIME

14:00

afternoon · disease appears quiet

JOINT SIGNAL

0:006:0012:0018:0024:00

Drag to move the appointment

WHAT THE DOCTOR WOULD RECORD

No visible inflammation. Examination unremarkable. Patient reports morning symptoms, none currently present.

estimated disease activity score 1.5

"The patient may say their joints were swollen and painful in the morning, but by the afternoon, when I examine them, there's nothing visible."

— Rheumatologist, LumiJoint customer discovery

10 of 14 rheumatologists named subjective assessment as a clinical concern.

LumiJoint customer discovery · 50 interviews

ACT 03 · MONITORING

A year of disease, two ways to see it.

Hover or drag across the year. Compare what each side captures.

Standard care vs. continuous monitoring across one year

Standard care · 4 visits per year

Continuous monitoring · 365 days per year

4 / 365
days seen · standard care
365 / 365
days seen · continuous monitoring

NEXT

How LumiJoint closes each blind spot.